Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair?

Journal Article (Review)

Currently available pharmaceuticals exert beneficial effects on morbidity and mortality in heart failure. Only cardiac transplantation, however, provides a definitive solution to the irreversible loss of cardiomyocytes in the failing heart. The limited availability of donor hearts leaves the vast majority of afflicted patients in need. The need for innovative approaches to improve care for these patients is apparent.

Full Text

Duke Authors

Cited Authors

  • Williams, RS

Published Date

  • November 1998

Published In

Volume / Issue

  • 16 / 4

Start / End Page

  • 739 - x

PubMed ID

  • 9891601

Pubmed Central ID

  • 9891601

International Standard Serial Number (ISSN)

  • 0733-8651

Digital Object Identifier (DOI)

  • 10.1016/s0733-8651(05)70048-5

Language

  • eng

Conference Location

  • Netherlands